Copyright Reports & Markets. All rights reserved.

Global Antifungal Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Antifungal Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Antifungal Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Antifungal Drugs Market Size Growth Rate by Type
    • 1.4.2 Azoles
    • 1.4.3 Echinocandins
    • 1.4.4 Polyenes
    • 1.4.5 Allylamines
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Antifungal Drugs Market Size Growth Rate by Application
    • 1.5.2 Dermatophytosis
    • 1.5.3 Aspergillosis
    • 1.5.4 Candidiasis
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Antifungal Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Antifungal Drugs Revenue 2015-2026
    • 2.1.2 Global Antifungal Drugs Sales 2015-2026
  • 2.2 Global Antifungal Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Antifungal Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Antifungal Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Antifungal Drugs Competitor Landscape by Players

  • 3.1 Antifungal Drugs Sales by Manufacturers
    • 3.1.1 Antifungal Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Antifungal Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Antifungal Drugs Revenue by Manufacturers
    • 3.2.1 Antifungal Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Antifungal Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Antifungal Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Antifungal Drugs Revenue in 2019
    • 3.2.5 Global Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Antifungal Drugs Price by Manufacturers
  • 3.4 Antifungal Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Antifungal Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Antifungal Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Antifungal Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Antifungal Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Antifungal Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Antifungal Drugs Revenue by Type (2015-2020)
    • 4.1.3 Antifungal Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Antifungal Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Antifungal Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Antifungal Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Antifungal Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Antifungal Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Antifungal Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Antifungal Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Antifungal Drugs Revenue by Application (2015-2020)
    • 5.1.3 Antifungal Drugs Price by Application (2015-2020)
  • 5.2 Antifungal Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Antifungal Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Antifungal Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Antifungal Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Antifungal Drugs by Country
    • 6.1.1 North America Antifungal Drugs Sales by Country
    • 6.1.2 North America Antifungal Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Antifungal Drugs Market Facts & Figures by Type
  • 6.3 North America Antifungal Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Antifungal Drugs by Country
    • 7.1.1 Europe Antifungal Drugs Sales by Country
    • 7.1.2 Europe Antifungal Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Antifungal Drugs Market Facts & Figures by Type
  • 7.3 Europe Antifungal Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Antifungal Drugs by Region
    • 8.1.1 Asia Pacific Antifungal Drugs Sales by Region
    • 8.1.2 Asia Pacific Antifungal Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Antifungal Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Antifungal Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Antifungal Drugs by Country
    • 9.1.1 Latin America Antifungal Drugs Sales by Country
    • 9.1.2 Latin America Antifungal Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Antifungal Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Antifungal Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Antifungal Drugs by Country
    • 10.1.1 Middle East and Africa Antifungal Drugs Sales by Country
    • 10.1.2 Middle East and Africa Antifungal Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Antifungal Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Antifungal Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description and Business Overview
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Antifungal Drugs Products Offered
    • 11.1.5 Novartis Related Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description and Business Overview
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Antifungal Drugs Products Offered
    • 11.2.5 Pfizer Related Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Corporation Information
    • 11.3.2 Sanofi Description and Business Overview
    • 11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sanofi Antifungal Drugs Products Offered
    • 11.3.5 Sanofi Related Developments
  • 11.4 Merck
    • 11.4.1 Merck Corporation Information
    • 11.4.2 Merck Description and Business Overview
    • 11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Merck Antifungal Drugs Products Offered
    • 11.4.5 Merck Related Developments
  • 11.5 Enzon Pharmaceuticals
    • 11.5.1 Enzon Pharmaceuticals Corporation Information
    • 11.5.2 Enzon Pharmaceuticals Description and Business Overview
    • 11.5.3 Enzon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Enzon Pharmaceuticals Antifungal Drugs Products Offered
    • 11.5.5 Enzon Pharmaceuticals Related Developments
  • 11.6 Bayer
    • 11.6.1 Bayer Corporation Information
    • 11.6.2 Bayer Description and Business Overview
    • 11.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Bayer Antifungal Drugs Products Offered
    • 11.6.5 Bayer Related Developments
  • 11.7 Astellas Pharma
    • 11.7.1 Astellas Pharma Corporation Information
    • 11.7.2 Astellas Pharma Description and Business Overview
    • 11.7.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Astellas Pharma Antifungal Drugs Products Offered
    • 11.7.5 Astellas Pharma Related Developments
  • 11.8 GlaxoSmithKline
    • 11.8.1 GlaxoSmithKline Corporation Information
    • 11.8.2 GlaxoSmithKline Description and Business Overview
    • 11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 GlaxoSmithKline Antifungal Drugs Products Offered
    • 11.8.5 GlaxoSmithKline Related Developments
  • 11.9 Abbott
    • 11.9.1 Abbott Corporation Information
    • 11.9.2 Abbott Description and Business Overview
    • 11.9.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Abbott Antifungal Drugs Products Offered
    • 11.9.5 Abbott Related Developments
  • 11.10 J & J
    • 11.10.1 J & J Corporation Information
    • 11.10.2 J & J Description and Business Overview
    • 11.10.3 J & J Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 J & J Antifungal Drugs Products Offered
    • 11.10.5 J & J Related Developments
  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description and Business Overview
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Antifungal Drugs Products Offered
    • 11.1.5 Novartis Related Developments
  • 11.12 Mylan
    • 11.12.1 Mylan Corporation Information
    • 11.12.2 Mylan Description and Business Overview
    • 11.12.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Mylan Products Offered
    • 11.12.5 Mylan Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Antifungal Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Antifungal Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Antifungal Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Antifungal Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Antifungal Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Antifungal Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Antifungal Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Antifungal Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Antifungal Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Antifungal Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Antifungal Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Antifungal Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Antifungal Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Antifungal Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Antifungal Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Antifungal Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Antifungal Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Antifungal Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Antifungal Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Antifungal Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Antifungal Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Antifungal Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Antifungal Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Antifungal Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Antifungal Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Antifungal Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antifungal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Antifungal Drugs market is segmented into
    Azoles
    Echinocandins
    Polyenes
    Allylamines
    Others

    Segment by Application, the Antifungal Drugs market is segmented into
    Dermatophytosis
    Aspergillosis
    Candidiasis
    Others

    Regional and Country-level Analysis
    The Antifungal Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Antifungal Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Antifungal Drugs Market Share Analysis
    Antifungal Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antifungal Drugs business, the date to enter into the Antifungal Drugs market, Antifungal Drugs product introduction, recent developments, etc.

    The major vendors covered:
    Novartis
    Pfizer
    Sanofi
    Merck
    Enzon Pharmaceuticals
    Bayer
    Astellas Pharma
    GlaxoSmithKline
    Abbott
    J & J
    Teva
    Mylan

    Buy now